Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.
about
Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D2-induced formation of anandamideThe reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users."Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.Opioid antagonism enhances marijuana's effects in heavy marijuana smokersSeparate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in miceBlood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposureSeparate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THCJWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeysSeparate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysisSeparate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinolInteractions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users.Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9) -THC in cannabis users.Subjective effects for alcohol, tobacco, and marijuana association with cross-drug outcomesDiscriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.Sex differences in the subjective effects of oral Δ9-THC in cannabis users.Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
P2860
Q28972550-48C6F105-A865-420B-A30A-CA08F0299061Q33989464-808D86E2-F7D2-4D38-8840-59BC8D555AC1Q34055910-EFDD71A3-2A38-4270-968E-85876034CD41Q34072888-9DE50435-37B0-4A18-90F5-1867DCBE2ED1Q34205968-9C9B3358-553E-4651-88DC-1F0FB40640F3Q34223229-5B1A9025-8BBC-4B36-9090-4D6B91ADFAB7Q34610855-426CACAE-FFCF-4A27-ABD3-EC0A837E0FF7Q34950909-3F0803D6-92D1-4AB0-8A88-DC4E32B98655Q35650744-84500D7C-98B4-461F-BA91-3779FF418518Q35840095-841989FE-63DF-46F3-8CCD-709AABCE3AB4Q36130597-B908013F-78E3-4A49-93A5-512A84180FCAQ36339147-70DED13D-8096-4FED-B593-C3CC2A944E74Q36624486-A54913E4-FE7D-4E3D-8E20-C5F655DC1B50Q36852576-D79CF5A5-0252-4802-99A6-81FD4E393883Q36930408-CD7374F7-CB64-4CC1-82BB-DFF03B7A902CQ36951509-52BA924A-99FD-4C3A-9511-21A63C580005Q37059561-10630FE3-6B7F-4B67-8C1A-602222511999Q37339113-C06BC82A-D33F-42F5-9255-6ED3931B63ACQ37397048-8A1BB2BD-FDBD-4BF6-8261-E710B3417E02Q38856900-385FD41D-C27F-49D7-B320-FF5AD65C3C75Q39762143-8A634800-01F0-45EA-B14D-8E7DB937C62BQ40094296-7201AF91-5220-4B21-9EC3-CF45B398F939Q45035724-589CC0BF-B264-4157-B0C6-C1BCE7055CFEQ50117427-0FF5BBA0-527D-4C96-B710-36CBF22DCCBA
P2860
Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Substitution profile of Delta9 ...... g Delta9-tetrahydrocannabinol.
@en
Substitution profile of Delta9 ...... g Delta9-tetrahydrocannabinol.
@nl
type
label
Substitution profile of Delta9 ...... g Delta9-tetrahydrocannabinol.
@en
Substitution profile of Delta9 ...... g Delta9-tetrahydrocannabinol.
@nl
prefLabel
Substitution profile of Delta9 ...... g Delta9-tetrahydrocannabinol.
@en
Substitution profile of Delta9 ...... g Delta9-tetrahydrocannabinol.
@nl
P2093
P2860
P1433
P1476
Substitution profile of Delta9 ...... g Delta9-tetrahydrocannabinol.
@en
P2093
David J Pinsky
Joshua A Lile
Lon R Hays
Thomas H Kelly
P2860
P2888
P304
P356
10.1007/S00213-008-1393-3
P577
2008-11-19T00:00:00Z